| Verbal-only (n = 69) | Verbal and numerical combined (n = 72) | p | ||
---|---|---|---|---|---|
n | % | n | % | ||
Gender | |||||
 Female | 45 | 35 | 46 | 36 |  |
 Male | 24 | 65 | 26 | 64 | .869 |
Age at time of experiment, mean (SD) | 57.72 (7.29) | Â | 56.83 (7.50) | Â | .469 |
 < 50 years | 8 | 11 | 13 | 18 |  |
 50–65 years | 44 | 64 | 49 | 68 |  |
 > 65 years | 17 | 25 | 10 | 14 | .201 |
Education | |||||
 Primary school | 8 | 11 | 12 | 17 |  |
 Secondary school | 17 | 25 | 24 | 33 |  |
College/University | 44 | 64 | 36 | 50 | .255 |
Tumor | |||||
 Breast | 22 | 32 | 22 | 31 |  |
 Hematologicala | 13 | 19 | 8 | 12 |  |
 Urologicalb | 10 | 15 | 13 | 18 |  |
 Gynecologicalc | 7 | 10 | 10 | 14 |  |
 Head and neck | 4 | 6 | 6 | 8 |  |
 Lung | 2 | 3 | 4 | 5 |  |
 Skin | 3 | 4 | 2 | 3 |  |
 Gastroenterologicald | 3 | 4 | 2 | 3 |  |
 Othere | 3 | 4 | 4 | 5 |  |
 Unknown | 2 | 3 | 1 | 1 | .912 |
Years since diagnosis, mean (SD) | 6.48 (6.89) | Â | 5.01 (4.22) | Â | .133 |
 0–5 years | 43 | 62 | 52 | 72 |  |
 6–10 years | 12 | 17 | 13 | 18 |  |
 11–15 years | 8 | 12 | 5 | 7 |  |
 > 15 years | 6 | 9 | 2 | 3 | .318 |
Treatment(s) | Â | Â | Â | Â | Â |
 Surgery | 48 | 70 | 48 | 67 | .712 |
 Radiotherapy | 40 | 58 | 35 | 49 | .266 |
 Chemotherapy | 40 | 58 | 37 | 51 | .433 |
 Immunotherapy | 13 | 19 | 11 | 15 | .574 |
 Hormone therapy | 18 | 26 | 24 | 33 | .347 |
 Other | 16 | 23 | 13 | 18 | .451 |
Prior experience side effects | |||||
 Fatigue | 55 | 80 | 49 | 68 | .116 |
 Neuropathy | 29 | 42 | 26 | 36 | .471 |
 Smell and taste changes | 30 | 44 | 27 | 38 | .470 |
 Diarrhea | 14 | 20 | 11 | 15 | .436 |
 None of the above | 7 | 10 | 9 | 13 | .659 |
Subjective numeracy, mean (SD)f | 4.51 (0.81) | Â | 4.64 (0.86) | Â | .384 |